On the 3rd, Iksu Pharmaceutical announced that its over-the-counter hangover relief product, 'Chueos Liquid (Samduhaejeong-tang)', surpassed cumulative sales of 2.77 million bottles in the third quarter of this year. The product, which has officially been recognized for its headache improvement effects, is gaining attention due to the significant proportion of headaches in hangover symptoms, leading to an increase in sales.

The Ministry of Food and Drug Safety will require all hangover relief products to submit human application test data starting January 2026. As of March last year, only 81 out of 177 products had secured such data, indicating potential market changes. According to Iksu Pharmaceutical, Chueos Liquid has secured a differentiated position by receiving approval from the Ministry for its efficacy in alleviating hangover headaches.

Chueos Liquid, a modern reinterpretation of 'Samduhaejeong-tang' from the Donguibogam (a Joseon Dynasty medical book), has been recognized for its indications in treating indigestion, vomiting, thirst, and headaches after excessive drinking. The Samduhaejeong-tang-based products include Chueos Liquid and Dionysus Liquid, both produced by Iksu Pharmaceutical.

Since its establishment in 1970, the company has accumulated traditional medicine manufacturing technology and recently changed its packaging from blue to red to refresh its brand image. It plans to increase market awareness through expanded marketing efforts. An Iksu Pharmaceutical representative stated, “Hangover headaches significantly impact daily work. This is a case where the value of a product with verified efficacy is further highlighted.”

Popular News